| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding | |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | Entrez:7422 MIM:192240 HGNC:HGNC:12680 Ensembl:ENSG00000112715 AllianceGenome:HGNC:12680 | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | |||||
| Description | vascular endothelial growth factor A | |||||
| GTO ID | GTC3488 |
| Trial ID | NCT05916391 |
| Disease | Diabetic Macular Edema |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | FT-003 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | An Open-label, Multy-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of FT-003 in Subjects With Diabetic Macular Edema |
| Year | 2023 |
| Country | China |
| Company sponsor | Frontera Therapeutics |
| Other ID(s) | FT003DM-1 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||
|
|||||